Biohaven [BHVN] vs Vericel [VCEL] Detailed Stock Comparison
Biohaven
NYSE
Loading...
Vericel
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Biohaven wins in 5 metrics, Vericel wins in 10 metrics, with 0 ties. Vericel appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biohaven | Vericel | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.64 | 255.21 | Biohaven |
| Price-to-Book Ratio | 12.35 | 5.87 | Vericel |
| Debt-to-Equity Ratio | 25.63 | 32.74 | Biohaven |
| PEG Ratio | 0.04 | 74.44 | Biohaven |
| EV/EBITDA | -1.39 | 190.23 | Biohaven |
| Profit Margin (TTM) | 0.00% | 2.85% | Vericel |
| Operating Margin (TTM) | 0.00% | -3.21% | Biohaven |
| Return on Equity | -295.94% | 2.59% | Vericel |
| Return on Assets (TTM) | -103.41% | 0.18% | Vericel |
| Free Cash Flow (TTM) | $-586.50M | $-5.81M | Vericel |
| 1-Year Return | -64.82% | -28.10% | Vericel |
| Price-to-Sales Ratio (TTM) | N/A | 7.24 | N/A |
| Enterprise Value | $1.29B | $1.81B | Vericel |
| EV/Revenue Ratio | N/A | 7.26 | N/A |
| Gross Profit Margin (TTM) | N/A | 73.71% | N/A |
| Revenue per Share (TTM) | $0 | $5 | Vericel |
| Earnings per Share (Diluted) | $-7.46 | $0.14 | Vericel |
| Beta (Stock Volatility) | 3.50 | 1.27 | Vericel |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Biohaven vs Vericel Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biohaven | -0.14% | 3.16% | 6.30% | -6.50% | -60.23% | -60.62% |
| Vericel | 0.23% | -0.92% | -0.06% | -13.71% | -31.85% | -35.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biohaven | -64.82% | 101.10% | 101.10% | -18.03% | -18.03% | -18.03% |
| Vericel | -28.10% | 30.92% | 116.49% | 1,017.98% | 26.57% | -92.06% |
Performance & Financial Health Analysis: Biohaven vs Vericel
| Metric | BHVN | VCEL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.66B | $1.80B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,885,210 | 456,322 |
| 90 Day Avg. Volume | 1,925,720 | 589,887 |
| Last Close | $14.68 | $35.44 |
| 52 Week Range | $12.79 - $55.70 | $33.09 - $63.00 |
| % from 52W High | -73.64% | -43.75% |
| All-Time High | $67.86 (Jun 03, 2019) | $1,590.00 (Sep 22, 1997) |
| % from All-Time High | -78.37% | -97.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.20% |
| Quarterly Earnings Growth | N/A | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.03% |
| Operating Margin (TTM) | 0.00% | -0.03% |
| Return on Equity (TTM) | -2.96% | 0.03% |
| Debt to Equity (MRQ) | 25.63 | 32.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.27 | $6.08 |
| Cash per Share (MRQ) | $3.83 | $2.32 |
| Operating Cash Flow (TTM) | $-645,078,016 | $47.24M |
| Levered Free Cash Flow (TTM) | $-508,353,632 | $-5,594,625 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Biohaven vs Vericel
| Metric | BHVN | VCEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.64 | 255.21 |
| Forward P/E | -2.49 | 74.44 |
| PEG Ratio | 0.04 | 74.44 |
| Price to Sales (TTM) | N/A | 7.24 |
| Price to Book (MRQ) | 12.35 | 5.87 |
| Market Capitalization | ||
| Market Capitalization | $1.66B | $1.80B |
| Enterprise Value | $1.29B | $1.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | 7.26 |
| Enterprise to EBITDA | -1.39 | 190.23 |
| Risk & Other Metrics | ||
| Beta | 3.50 | 1.27 |
| Book Value per Share (MRQ) | $1.27 | $6.08 |
Financial Statements Comparison: Biohaven vs Vericel
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BHVN | VCEL |
|---|---|---|
| Revenue/Sales | $0 | $52.60M |
| Cost of Goods Sold | N/A | $16.33M |
| Gross Profit | N/A | $36.27M |
| Research & Development | $187.58M | $7.26M |
| Operating Income (EBIT) | $-221.56M | $-12.79M |
| EBITDA | $-219.32M | $-8.41M |
| Pre-Tax Income | $-221.07M | $-11.25M |
| Income Tax | $609,000 | N/A |
| Net Income (Profit) | $-221.68M | $-11.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BHVN | VCEL |
|---|---|---|
| Cash & Equivalents | $98.42M | $73.49M |
| Total Current Assets | $382.76M | $197.64M |
| Total Current Liabilities | $164.03M | $39.45M |
| Long-Term Debt | $30.80M | $87.80M |
| Total Shareholders Equity | $259.50M | $295.49M |
| Retained Earnings | $-1.57B | $-404.06M |
| Property, Plant & Equipment | $36.78M | $68.72M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BHVN | VCEL |
|---|---|---|
| Operating Cash Flow | $-164.28M | $12.44M |
| Capital Expenditures | $-461,000 | N/A |
| Free Cash Flow | $-165.59M | $-7.61M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BHVN | VCEL |
|---|---|---|
| Shares Short | 12.71M | 5.56M |
| Short Ratio | 6.72 | 9.32 |
| Short % of Float | 0.14% | 0.14% |
| Average Daily Volume (10 Day) | 1,885,210 | 456,322 |
| Average Daily Volume (90 Day) | 1,925,720 | 589,887 |
| Shares Outstanding | 101.22M | 49.63M |
| Float Shares | 88.38M | 49.90M |
| % Held by Insiders | 0.12% | 0.01% |
| % Held by Institutions | 0.83% | 1.11% |
Dividend Analysis & Yield Comparison: Biohaven vs Vericel
| Metric | BHVN | VCEL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |